Selection bias |
Skew in the selection of study participants |
Patients with strong family history may self-select for study participation; patients with strong family history may be more likely to be referred to tertiary care and research centers |
Survivor bias (prevalence-incidence bias) |
Selection of study participants may miss mild disease or severe fatal cases |
Patients whose first myocardial infarction is fatal are less likely to be studied |
Recall bias |
Patients are more likely to recall an environmental exposure if it was linked to a negative outcome |
Patients with CAD may be more likely to remember an environmental exposure because of its negative consequences |
Respondent bias |
Patients answer in the way they believe they should answer, not the true answer |
Patients with CAD and knowledge of potential CAD risk factors will be more motivated to report those exposures |
Family information bias |
Individuals become more aware of exposure if it is prevalent in their family |
Many CAD risk factors and environmental exposures cluster in families |
Exposure suspicion bias |
Disease status can affect the amount of environmental exposure history collected |
If data collection is not standardized, investigators may more thoroughly query patients with CAD |
Publication bias |
Statistically significant findings are more likely to be published |
Gene-gene and gene-environment interaction findings in CAD are more likely to be published if significant |
Measurement bias |
Systematic errors of measurement |
Platform- or laboratory-dependent genotyping errors; errors of laboratory values; errors of environmental exposure measurement |
Population stratification |
Differences in allele frequencies between groups resulting from ancestry not outcome status |
CAD prevalence varies between ethnicities; but this can be tested and corrected for using methodological and statistical techniques |